Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tumor cell plasma membrane is the outermost boundary of cancer cells, composed primarily of a lipid bilayer interspersed with proteins and carbohydrates. It serves as a dynamic barrier that regulates the transport of molecules in and out of the cytoplasm, mediates cell signaling, and interacts with the extracellular matrix (ECM) and tumor microenvironment. The composition and organization of this membrane are distinct from those in normal cells, contributing to hallmark cancer behaviors such as increased proliferation, resistance to apoptosis, metastasis, and drug resistance. Specific components like overexpressed surface proteins and altered lipid composition are exploited for targeted therapies and drug delivery.
Varies depending on the specific target within the membrane (e.g., receptor antagonists, inhibitors of efflux pumps, drugs modifying lipid composition). Antibody-drug conjugates bind to specific antigens and deliver cytotoxic payloads.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Cell Plasma Membrane (PM).